Cargando…
Interactions Between Plasma Amyloid and Aging Markers to Determine Clinically Meaningful Cognitive Decline
Background: Brain amyloidosis is a well-known pathological hallmark of Alzheimer’s disease (AD) and can be early identified by measuring plasma amyloid-β (Aβ) status. Growing evidence implicates the biological mechanisms of aging, including chronic inflammation, mitochondrial dysfunction and neurode...
Autores principales: | Lu, Wan-Hsuan, Giudici, Kelly, Vellas, Bruno, de Barreto, Philipe Souto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681056/ http://dx.doi.org/10.1093/geroni/igab046.2607 |
Ejemplares similares
-
Assessment of Plasma Amyloid-β(42/40) and Cognitive Decline Among Community-Dwelling Older Adults
por: Giudici, Kelly Virecoulon, et al.
Publicado: (2020) -
Body Weight Variation Patterns as Predictors of Cognitive Decline over a 5 Year Follow-Up among Community-Dwelling Elderly (MAPT Study)
por: Giudici, Kelly Virecoulon, et al.
Publicado: (2019) -
Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults
por: He, Lingxiao, et al.
Publicado: (2021) -
Plasma MCP-1 and changes on cognitive function in community-dwelling older adults
por: Sanchez-Sanchez, Juan Luis, et al.
Publicado: (2022) -
Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
por: Molet-Benhamou, Luc, et al.
Publicado: (2022)